Sai Parenterals Q2 FY27 Consolidated Results and Corporate Actions
Sai Parenterals Ltd · Financial Result · 01 Nov 2026, 9:34 pm
Sai Parenterals Q2 FY27 Consolidated Results and Corporate Actions Sai Parenterals reported consolidated Q2 revenue from operations of ₹1,949.18 mn for the quarter ended 30th Sep'26, up 264.1% YoY from ₹535.28 mn and 9.1% QoQ from ₹1,786.72 mn. Profit after tax rose 65.5% YoY to ₹105.10 mn (Q1: ₹79.23 mn), with EPS at ₹2.38. The board approved acquiring the remaining 25% stake in SP Analytics for ₹25,000 to make it a wholly owned subsidiary by 31st Dec'26, and confirmed completing the 60% stake acquisition in Saicriti Pharma.
Original exchange filing (PDF)
More announcements from Sai Parenterals Ltd
- Press Release by Sai Parenteral''s Limited · 17 Nov 2026
- Outcome of Board Meeting held on Monday, 16th November, 2026 · 17 Nov 2026
- call conducted on Monday the 2nd day of November, 2026. · 07 Nov 2026
- Audio recording of earning call held on 2nd November, 2026 over call. · 03 Nov 2026
- Investor Presentation for the quarter and half year ended 30th September, 2026 · 02 Nov 2026
- Investor press release on standalone and consolidated unaudited financial results for the quarter ended 30th September, 2026. · 01 Nov 2026
- Statement of variation and deviation for the period ended 30th September, 2026 · 01 Nov 2026
- Sai Parenterals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 01 Nov 2026
